Corvus Pharmaceuticals (CRVS) Other Non-Current Assets (2022 - 2025)
Historic Other Non-Current Assets for Corvus Pharmaceuticals (CRVS) over the last 4 years, with Q3 2025 value amounting to $852000.0.
- Corvus Pharmaceuticals' Other Non-Current Assets rose 23809.52% to $852000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $852000.0, marking a year-over-year increase of 23809.52%. This contributed to the annual value of $632000.0 for FY2024, which is 61011.24% up from last year.
- Per Corvus Pharmaceuticals' latest filing, its Other Non-Current Assets stood at $852000.0 for Q3 2025, which was up 23809.52% from $626000.0 recorded in Q2 2025.
- Corvus Pharmaceuticals' 5-year Other Non-Current Assets high stood at $852000.0 for Q3 2025, and its period low was $89000.0 during Q3 2023.
- Over the past 4 years, Corvus Pharmaceuticals' median Other Non-Current Assets value was $236000.0 (recorded in 2022), while the average stood at $299600.0.
- In the last 5 years, Corvus Pharmaceuticals' Other Non-Current Assets crashed by 6411.29% in 2023 and then soared by 61011.24% in 2024.
- Quarter analysis of 4 years shows Corvus Pharmaceuticals' Other Non-Current Assets stood at $129000.0 in 2022, then crashed by 31.01% to $89000.0 in 2023, then surged by 610.11% to $632000.0 in 2024, then skyrocketed by 34.81% to $852000.0 in 2025.
- Its Other Non-Current Assets stands at $852000.0 for Q3 2025, versus $626000.0 for Q2 2025 and $629000.0 for Q1 2025.